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A rhodium(III) complex, rac-[Rh(bpy)2phzi]3 (bpy, 2,2-bipyri-
dine; phzi, benzo[a]phenazine-5,6-quinone diimine) has been
designed as a sterically demanding intercalator targeted to de-
stabilized mismatched sites in double-helical DNA. The complex
is readily synthesized by condensation of the phenazine qui-
none with the corresponding diammine complex. Upon photo-
activation, the complex promotes direct strand scission at single-
base mismatch sites within the DNA duplex. As with the parent
mismatch-specific reagent, [Rh(bpy)2(chrysi)]3 [chrysene-5,6-
quinone diimine (chrysi)], mismatch selectivity depends on the
helix destabilization associated with mispairing. Unlike the par-
ent chrysi complex, the phzi analogue binds and cleaves with
high affinity and efficiency. The specific binding constants for
CA, CC, and CT mismatches within a 31-mer oligonucleotide
duplex are 0.3, 1, and 6  107 M1, respectively; site-specific
photocleavage is evident at nanomolar concentrations. More-
over, the specificity, defined as the ratio in binding affinities for
mispaired vs. well paired sites, is maintained. The increase in
affinity is attributed to greater stability in the mismatched site
associated with stacking by the heterocyclic aromatic ligand. The
high-affinity complex is also applied in the differential cleavage
of DNA obtained from cell lines deficient in mismatch repair vs.
those proficient in mismatch repair. Agreement is found be-
tween photocleavage by the mismatch-specific probes and defi-
ciency in mismatch repair. This mismatch-specific targeting,
therefore, offers a potential strategy for new chemotherapeutic
design.
The targeting of single-base mismatches in DNA representsa challenging problem in molecular recognition. The mis-
matched site may be of variable sequence and within a vari-
able sequence context. What distinguishes such a site, instead,
is the local destabilization in opposing bases because of the
absence of Watson–Crick hydrogen bonding (1). Although
challenging, however, the development of small molecules tar-
geted to mismatches offers many applications. Site-specific
mismatch probes could be used in discovery efforts to identify
single-nucleotide polymorphisms. Moreover, such molecules
could provide the basis for the development of novel chemo-
therapeutics. Many cancers are associated with a deficiency in
mismatch repair (2, 3). Hence, by directing small molecules to
the accumulated mismatches, a cancer-specific targeting strat-
egy could be envisioned.
In our laboratory, we have exploited the local helix destabi-
lization associated with mispairing in the design of a metal
complex targeted to mismatches (4, 5). Shown in Fig. 1 is a
rhodium complex containing the benzo[a]phenazine-5,6-qui-
none diimine (phzi) ligand, as well as chrysene-5,6-quinone
diimine (chrysi) and phenanthrene quinone diimine (phi) li-
gands (4). Octahedral rhodium(III) complexes containing the
phi ligand bind avidly to double-helical DNA by intercalation
(6); on photoactivation, direct DNA strand cleavage is also
promoted at the bound site (7). By tuning the ancillary li-
gands, complexes can be prepared that are either site-specific
or sequence-neutral. [Rh(bpy)phi2]3 (bpy, 2,2-bipyridine),
for example, binds to B-DNA with little site selectivity (7),
whereas [Rh(S,S-dimethyltrien)(phi)]3 specifically targets the
sequence 5-TGCA-3 (8). The high-resolution crystal struc-
ture of [Rh(S,S-dimethyltrien)(phi)]3 bound to a DNA oc-
tamer shows site-specific intercalation by the complex from
the major groove side of the helix, with site-discrimination
determined through an ensemble of hydrogen bonding con-
tacts and methyl–methyl interactions (9). The intercalated phi
ligand itself resembles another base pair, stacked at a distance
of 3.4 Å between neighboring base pairs, with an expanse
across the ligand of dimensions matching that of the base
pairs above and below.
The chrysi complex represents our first-generation complex
targeted to mismatches (4). The site-specificity of the complex
is derived from the fact that it is a more bulky intercalator
with an expanse exceeding that of the well matched base pair
(Fig. 1). Owing to shape selection, the complex is unable to
bind to well matched B-form DNA. However, at sites where a
base pair is destabilized, intercalation of the chrysi complex
can occur. [Rh(bpy)2chrysi]3 has been shown to be both a
general and a remarkably specific mismatch recognition agent
(10, 11). Specific DNA cleavage is observed at 80% of mis-
match sites in all of the possible single base-pair sequence
contexts around the mispaired bases. Moreover, the complex
was found to recognize and photocleave at a single base mis-
match in a 2,725-bp linearized plasmid heteroduplex.
Here, we describe the synthesis and application of a second
generation mismatch recognition agent, [Rh(bpy)2phzi]3.
This complex shares with the chrysi complex a sterically de-
manding intercalating ligand. However, the phzi ligand, as an
aromatic heterocycle, offers the possibility of greater stabili-
zation through stacking within the mismatched site. Indeed,
[Rh(bpy)2phzi]3 binds mismatched sites with a binding affin-
ity increased by two orders of magnitude, without a loss in
site-selectivity. This high affinity allows the application of the
complex in the differential targeting of DNA in a mismatch-
repair-deficient cell line.
Materials and Methods
Materials. Commercially obtained chemicals were used as re-
ceived. Bipyridine, trif lic acid, 2,3-dichloro-1,4-naphthoqui-
none, and phenylenediamine were purchased from Aldrich.
RhCl32H2O was obtained from Pressure Chemical (Pitts-
burgh). Benzo[a]phenazinequinone was synthesized as de-
scribed (12).
Instrumentation. Electronic spectra were recorded on a Beck-
man DU 7400 UV-visible spectrophotometer (Beckman
Coulter). Mass spectra [electrospray ionization (ESI)] were
measured on an LCQ mass spectrometer. High-performance
liquid chromatography was performed on a Waters 996 sys-
tem using a Vydac C18 column (4.0 mlmin liquid phase, lin-
ear gradient over 50 min from 100% 50 mM NH4OAc, pH
Abbreviations: phzi, benzo[a]phenazine-5,6-quinone diimine; chrysi, chrysene-5,6-
quinone diimine; phi, phenanthrene quinone diimine; bpy, 2,2-bipyridine.
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7.0, to 100% acetonitrile). NMR spectra were recorded on a
Varian Mercury 300 MHz instrument. DNA synthesis was
performed on an ABI 392 DNARNA synthesizer (Applied
Biosystems) by using reagents from Glen Research. DNA was
purified by using Glen Research PolyPak II cartridges (Glen
Research, Sterling, VA), followed by reverse phase HPLC.
Photocleavage reactions were carried out by using a 1,000-W
Oriel HgXe arc lamp (Oriel, Stamford, CT) with a mono-
chromator fitted with a 300-nm cutoff filter and an IR filter.
Synthesis and Characterization: rac-[Rh(bpy)2phzi]Cl3. rac-
[Rh(bpy)2(phzi)]Cl3 was synthesized by using the o-quinone
condensation method previously used in the synthesis of
[Rh(bpy)2(chrysi)]Cl3 (13). [Rh(bpy)2(NH3)2]OTf3 (100 mg,
0.1 mmol) and benzo[a]phenazinequinone (35 mg, 0.125
mmol) were prepared according to the literature procedure
(12, 14). These were dissolved in dry acetonitrile (50 ml).
Aqueous sodium hydroxide (2 ml, 0.2 M) was added, and the
solution was rapidly stirred for 30 min at ambient tempera-
ture. The reaction was quenched with the addition of 35 ml
of water and 0.2 N HCl to neutralize. The acetonitrile was
removed in vacuo. The remaining solution was filtered from
the brown solid and loaded on a CM-C25 Sephadex cation
exchange column (resin equilibrated with 0.05 M MgCl2).
A yellow compound, likely the metal-free ligand, eluted with
the initial volume. After rinsing with water, 0.05 M MgCl2, a
green fraction, elutes. It was collected and concentrated on a
Seppac-C18 column, eluted with a mixture of acetonitrile,
water, and TFA (1:1:0.001), and lyophilized to dryness. The
yield was 23 mg (30% yield). Microanalysis found (calculat-
ed): C 54.8 (55.4), H 3.6 (3.3), N 15.3 (14.8). (1)H NMR
(d6-DMSO, 300 MHz):  14.88 (s), 14.70 (s), 9.03 (m, 4H),
8.90 (d, 2H, 7.2 Hz), 8.72 (d, 1H, 6.1 Hz), 8.60 (t, 2H, 8.5
Hz), 8.54 (d, 1H, 6.1 Hz), 8.47 (t, 2H, 8.5 Hz), 8.32 (d, 1H,
8.5 Hz), 8.20 (d, 1H, 8.5 Hz), 8.11 (t, 1H, 7.3 Hz), 8.03
(m, 3H), 7.94 (t, 1H, 6.1Hz), 7.84 (t, 1H, 7.3Hz), 7.75
(m, 3H), 7.69 (d, 1H, 6.1 Hz) ppm. UVvis (H2O, pH 5): 245
nm (89,800 M1cm1), 304 nm (65,800 M1cm1), 314 nm
(67,300 M1cm1), 343 nm (39,300 M1cm1). ESI-MS-
(cation) 671(M-2H) observed, 671 calculated.
DNA Preparation and Photocleavage Experiments. The oligonucle-
otides, 5-GAT GTC GGT CCC ACG ATG GTG ACG GAT
TAC C-3 and 5-GAG TTG GTA ATC CGT CAC CAT
CGT GCG ACC GAC ATC ATG CG-3, where C denotes
the position of the mismatch, were synthesized on an ABI 392
DNARNA synthesizer (Applied Biosystems) by using stan-
dard phosphoramidite solid-phase synthesis; they were initially
purified on PolyPak II cartridges and further purified by
HPLC (98% 100 mM NH4OAc2% acetonitrile to 70% 100
mM NH4OAc30% acetonitrile over 30 min). The single
strands were then 5-labeled with [-32P]ATP and T4 polynu-
cleotide kinase. The labeled strands were further purified by
gel electrophoresis (20% denaturing polyacrylamide gel),
eluted from the gel by soaking in triethylammonium acetate
(100 mM, pH 7.0), ethanol precipitated, and annealed in the
presence of unlabeled DNA. To the labeled 3141-mer duplex
(2 M in 50 mM NaCl10 mM TrisHCl, pH 8.5) was added
either [Rh(bpy)2phzi]Cl3 or [Rh(bpy)2chrysi]Cl3, and the sam-
ple was irradiated. After irradiation, all samples were lyophi-
lized, denaturing formamide loading dye was added, and the
samples were electrophoresed on a 20% polyacrylamide dena-
turing gel. The photocleavage results were quantitated by
phosphorimagery (PhosphorImager, Molecular Dynamics).
Mismatch-Repair-Proficient and -Deficient Cell Lines and Photo-
cleavage of Genomic DNA. Cell lines were obtained from the
National Cancer Institute cell repository (National Cancer
Institute-Frederick Cancer Research and Development Cen-
ter, Frederick, MD). DNA was isolated according to standard
methods (15). Isolated DNA was digested with EcoRI, de-
phosphorylated with shrimp alkaline phosphatase (SAP), and
radiolabeled with [-32P]ATP, as follows: 100 l of 100 M
solution of DNA from each cell line contained 10 l of 10
EcoRI buffer, to which 5 l of EcoRI (NEB, Beverly, MA)
was added. The reactions were allowed to incubate at 37°C
for 8 h. The solutions then were put through Bio-Rad mi-
crofuge exchange spin columns and subsequently treated with
10 l of 10 SAP buffer and 7 l of SAP. The solutions
were allowed to incubate at 37°C for at least 4 h before deac-
tivation by heating at 65°C for 15 min. The solutions then
were put through Bio-Rad exchange columns once again and
subsequently treated with 10 l of 10 T4 polynucleotide ki-
nase (PNK buffer: 70 mM TrisHCl, pH 7.610 mM MgCl2,5
mM DTT), 3 l of [-32P]ATP (ICN) and 5 l of PNK
(NEB). The reactions were allowed to incubate at 37°C over-
night, after which time, excess ATP was removed with Bio-
Rad microfuge exchange spin columns. Samples were then
lyophilized and extracted into 100 l 10 mM TE buffer (10
mM TrisHCl1 mM EDTA, pH 7.2).
DNA was then treated with [Rh(bpy)2(chrysi)]3 or
[Rh(bpy)2(phzi)]3 and irradiated. For each cell line, control
samples, containing either metal complex without irradiation
or irradiation in the absence of metal complex, were also pre-
pared and analyzed. Samples being photolyzed were exposed
Fig. 1. Bulky metallointercalators. (Top) [Rh(bpy)2(phzi)]3. (Middle) The
phi, chrysi, and phzi intercalating ligands. (Bottom) A view of intercalation of
the Rh(phi) moiety (red) within a well matched DNA site (blue). The view of
intercalation (based upon crystallographic coordinates; ref. 9) shows the snug
fit of the phi ligand within its binding site. The bulky chrysi and phzi ligands
are precluded sterically from intercalation in a similar fashion.
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to 440 nm light for 5 min. All samples were then lyophilized
and extracted into 10 l of 8 M urea loading dye and heated
at 90°C for 2 min. The samples were then treated with 10 l
of 2 alkaline gel buffer and loaded on an alkaline denatur-
ing 1% agarose gel and electrophoresed.
The gels were visualized and quantitated by using IMAGE-
QUANT software. Line integration down the center of the
lanes was carried out to give a quantitative distribution of
fragment intensity as a function of gel mobility. The distribu-
tion curves were then normalized by using ORIGIN. The dark
control data were plotted for each cell line and fit to a
Gaussian curve to obtain a midpoint. The raw, normalized
intensity data up to the control midpoint for each cell line
were then subtracted from the raw, normalized intensity data
for the control. The resulting areas were then integrated to
obtain relative values of shift in size distribution. These values
were then averaged over several trials.
Results
Synthesis and Spectral Characterization of [Rh(bpy)2phzi]Cl3.
[Rh(bpy)2phzi]Cl3 was prepared as illustrated in Fig. 2. The
complex may be readily synthesized by using the condensation
method (13). The benzo[a]phenazine quinone is made by the
reaction of 2,3-dichloro-1,4-napthoquinone with o-phenylene-
diamine in pyridine, followed by oxidation with nitric acid
(12). Separately, [Rh(bpy)2(NH3)2](OTf)3 is synthesized (14),
and then the condensation reaction is carried out in an H2O
acetonitrile solution-containing base. The reaction, as moni-
tored by HPLC, is essentially complete after 30 min at ambi-
ent temperatures. The condensation method is significantly
less cumbersome than reaction involving direct coordination
of either the quinone diamine or diimine. Moreover, the reac-
tion is also more facile than that with the chrysine quinone,
given the lower extent of steric crowding around the conden-
sation sites.
Spectral characterization for [Rh(bpy)2phzi]3 resembles
that for the parent phi and chrysi complexes. The spectrum
consists of contributions from ligand to metal charge-transfer
states near 310 nm and two ligand-centered transitions near
350 and 400 nm. Changes in the spectrum as a function of pH
are consistent with deprotonation of the diimmine at pH 5,
similar to that for the chrysi complex.
DNA Photocleavage of a Single Base Mismatch. As is evident in
Fig. 3, photoactivation of [Rh(bpy)2phzi]3 bound to a mis-
matched site leads to direct strand cleavage. Upon photoacti-
vation of [Rh(bpy)2phzi]3 in the presence of a mismatch-
containing DNA duplex, site-specific photocleavage is
observed at the base 3- to the mismatch site. Both the posi-
tion of strand cleavage and the level of specificity are in ac-
cordance with that seen with the chrysi complex. Signifi-
cantly, however, specific cleavage of the mismatch site by
[Rh(bpy)2phzi]3 can be seen at metal concentrations as low
as 10 nM.
Titrations as a function of concentration, where the ratio of
metalDNA is kept constant, can be used to establish the
specific binding constant to an individual site. Fig. 4 shows
the quantitation for such a photocleavage titration. The spe-
cific binding constant for [Rh(bpy)2phzi]3 at the CC mis-
match in this oligonucleotide is 1  107 M1. This compares
to a value of 3  105 M1 for [Rh(bpy)2chrysi]3 under com-
parable conditions.
Not only does [Rh(bpy)2phzi]3 bind more tightly to mis-
matched sites, photoactivation experiments also reveal that
the complex has approximately a fivefold higher photoeffi-
ciency than the chrysi analogue in cleaving the CC mismatch.
The last three lanes in Fig. 3 also show the photoefficiency
for the complex at different wavelengths. Remarkably, the
cleavage can be seen even at visible wavelengths of 525 nm.
Site-specific binding by [Rh(bpy)2phzi]3 can also be com-
pared quantitatively to nonspecific binding to well matched
sites on the duplex (Fig. 4). For this oligonucleotide, the high-
est cleavage intensity other than that for the CC site is evi-
dent within the duplex region 5-GTCGG-3. The determina-
tion of the binding constant for this site yielded a value of
4  105 M1, almost two orders of magnitude weaker than
that for the mismatch. The basis for reaction at this site is
unclear. This site represents the highest well matched site af-
finity, so that the average nonspecific affinity is weaker. This
level of specificity is comparable to that seen with the chrysi
complex (4).
[Rh(bpy)2phzi]3 targets not only the CC mismatch but
other mismatches as well. The full family of mismatches was
examined through photocleavage experiments on a 31-bp oli-
gomer by varying the base sequence at the central mismatch
site. The pyrimidine mismatches in particular, including CT,
TT, and TC, are also readily cleaved. By quantitative photo-
cleavage titration, the binding affinity for the CA mismatch is
found to be 3  106 M1, whereas that for CT is 6  107
M1. Overall, targeting seems to be mismatch-specific, not
base-specific. As with the parent chrysi complex, then, site-
specificity depends on the local helix destabilization associ-
ated with mispairing.
Also of interest, whereas [Rh(bpy)2phzi]3 has the ability to
target a variety of different mismatches with high affinity, it is
not able to cleave all mismatches with equal photoefficiency.
This variation may be determined through quantitative photo-
cleavage titration; at maximum binding, different intensities
of photocleavage are observed. The different photoefficien-
cies can be understood in terms of variations in bound geom-
etries within the different mismatch site, because photocleav-
age is expected to depend on access of the photoexcited
ligand radical to hydrogen atoms on the sugar (7). Several
mismatches, such as the CC and TT, are cleaved with much
better efficiency than with [Rh(bpy)2(chrysi)]3; others, such
as CA, are bound tightly but do not exhibit efficient cleavage.
Fig. 2. Synthetic scheme for rac-[Rh(bpy)2(phzi)]3 using the condensation strategy.
Junicke et al. PNAS  April 1, 2003  vol. 100  no. 7  3739
CH
EM
IS
TR
Y
SP
EC
IA
L
FE
A
TU
RE
Photocleavage of DNA from Cell Lines Proficient or Deficient in
Mismatch Repair. As a test of the specificity and applicability of
these complexes, photocleavage was also carried out on
genomic DNA isolated from human cancer cell lines with or
without compromised mismatch repair. Specifically, the
HCT15, SW620, SKOV3, and DU145 cell lines were used.
SW620 cells are fully competent in mismatch repair. HCT15
cells have an MSH6 mutation. SKOV3 and DU145 cells, con-
taining mutations in MLH1 and both MLH1 and PMS2, re-
spectively, are deficient in mismatch repair (2, 3, 16–19).
The genomic DNA was first digested into 5-kb lengths by
restriction, radioactively end-labeled, treated with either
[Rh(bpy)2chrysi]3 or [Rh(bpy)2phzi]3, and irradiated. Anal-
ysis involved integration of lower molecular weight bands
found after denaturing agarose gel electrophoresis of the frag-
ments. Fig. 5 shows relative levels of photocleavage obtained.
Significant cleavage is evident with [Rh(bpy)2phzi]3 at 50
nM concentration for DNA from SKOV3 and DU145, the
two cell lines that lack MLH1. A low level of photocleavage is
apparent with HCT15, lacking MSH6, and no significant
cleavage over the controls is apparent with SW620, a cell line
competent in mismatch repair. The photocleavage results cor-
relate directly with independent analyses of these cell lines for
microsatellite instabilities (16–19).
Similar trends are evident for the chrysi complex, although
higher concentrations of the metal complex must be used and
only a small differential effect is apparent. Interestingly, the
highest level of discrimination in cleavage among the different
cell lines was found at 0.1 nM [Rh(bpy)2phzi]3.
Discussion
Design of a High-Affinity Reagent Targeted to Mismatches. A mis-
match recognition agent has been synthesized with a hetero-
Fig. 3. (a) Phosphoimagery of 20% polyacrylamide gels shows mismatch-specific cleavage by the rhodium(III) complex after DNA photocleavage by 1 M
[Rh(bpy)2chrysi]Cl3 (BC) and 0.1–100 M [Rh(bpy)2phzi]Cl3 (BZ) on 5-32P-labeled (indicated by *) CC mismatch-containing 3141-mer DNA duplex (1 M).
(b) All samples were prepared in 10 mM Tris, pH 8.050 mM NaCl. All irradiations were at 313 nm for 15 min after DNA photocleavage by varying the concentration
of [Rh(bpy)2chrysi]Cl3 (BC) and [Rh(bpy)2phzi]Cl3 (BZ), as well as at different wavelengths for [Rh(bpy)2phzi]Cl3. It is notable that BC does not cleave the DNA at
concentrations up to 100 nM, whereas BZ already shows a cleavage at 10 nM at the mismatch site. AG and CT, Maxam-Gilbert sequencing reactions; DC, dark
control DNA sample without irradiation; LC, the light control sample irradiated in the absence of metal complex.
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cyclic aromatic ligand system based on the condensation tech-
nique. As with the parent rhodium intercalators,
[Rh(bpy)2phzi]3 promotes direct strand cleavage at its target
site with photoactivation. Importantly, photocleavage experi-
ments using [Rh(bpy)2phzi]3 show that this intercalator can
recognize DNA mismatches with very high specificity at con-
centrations in the nanomolar range.
The fact that this bulky intercalator, like the parent chrysi
complex, is able to specifically target mismatches suggests the
generality of this targeting strategy. By increasing the expanse
of the intercalating ligand beyond that of a base pair, bind-
ing to well matched DNA sites is disfavored owing to shape-
selection. Given the inherent destabilization associated with
mismatched sites, however, binding within such sites is
energetically more favorable. The specificity for a mismatch,
therefore, does not depend on base sequence directly nor the
presence or absence of specific functionalities in the major or
minor groove. Instead, recognition is associated with the local
helix instability of a mispair. Any sequence dependence ob-
served, therefore, should be related to the sequence depen-
dence of mismatch stability (1).
The specificity of [Rh(bpy)2phzi]3 resembles that for
[Rh(bpy)2chrysi]3 (11). This observation also supports the
general targeting strategy. Because the expanse of the recog-
nition ligand is comparable for the two complexes, one ex-
pects a comparable level of discrimination vs. well matched
B-DNA sites. It is interesting, nonetheless, that the disposi-
tion of the phzi ligand somewhat further from the octahedral
center than for chrysi does not lead to a relative loss of
specificity.
The primary source of increased sensitivity of targeting
with [Rh(bpy)2phzi]3 is derived from the increase in binding
affinity, both for specific and nonspecific sites. This significant
increase in affinity can be attributed to the presence of the
endocyclic nitrogen atoms within the phzi ligand. The in-
creased polarizability of the phzi ligand as compared with the
chrysi ligand leads to increased stabilization through stacking.
Intercalative stacking in DNA, in contrast to groove binding,
is favored not through hydrophobic interactions but through
dipole-induced dipole interactions associated with heterocyclic
aromatic ligands (20). This increased affinity of the phzi com-
plex containing the endocyclic nitrogens serves as an illustra-
tion of the affinity to be gained through polarized stacking.
Indeed, the increase in affinity suggests that the phzi is inter-
calatively stacked within the mismatched site; the positioning
of the mismatched bases is unclear, however. Thus, in addi-
tion to shape considerations, a tuning of the electronic struc-
ture by using nitrogen substitution in the aromatic ring results
in mismatch targeting with increased affinity.
Differential Targeting of DNA from Mismatch Repair Deficient vs.
Proficient Cell Lines. Mismatch repair increases the level of fi-
delity of replication, but if the mismatch repair system does
not function properly, mispairs can accumulate (21). Failure
of mismatch repair results in microsatellite instability, and this
result has provided the common assay for mismatch repair
within cells. Here, we describe discrimination among genomic
DNAs based on small molecule recognition of mismatches.
Our results show agreement between earlier studies of mic-
rosatellite instability and expression of mismatch repair pro-
teins in various cell lines (16–19) vs. photocleavage by the
mismatch probes. A significant level of photocleavage is ap-
parent with DU145 cells, which contain mutations in MLH1
and PMS2; these mutations are expected to severely compro-
mise the mismatch repair system. Indeed, particularly low
mismatch repair activity has been seen with this cell line (19).
For SKOV3 cells, mutations are present in MLH1 but not in
PMS2. Consistent with mismatch accumulation in this cell
line, significant photocleavage of genomic DNA from SKOV3
cells is found. It is noteworthy that photocleavage here occurs
to a lesser extent than for DU145 DNA. Importantly, no sig-
nificant photocleavage is apparent on genomic DNA from
SW620 cells, a cell line proficient in mismatch repair. Inter-
estingly, for HCT15 DNA, little photocleavage above controls
is evident. This cell line is deficient in MSH6, but owing to
redundancy in the mismatch repair system, such a mutation is
not expected to lead to mismatch accumulation and, consis-
tent with our results, increases in microsatellite instability are
not observed (20). Hence, our photocleavage results provide a
Fig. 4. Binding isotherms for [Rh(bpy)2phzi]3 targeted to a CC mismatch-
containing oligonucleotide (F) and the highest affinity well matched (E) site
in the same duplex. Photocleavage reactions were performed at 313 nm for 15
min. The concentration of the oligomer varied from 1  1010 to 4  104 M
with the rhodium complex at a 10-fold lower concentration. Samples
were eluted through 20% denaturing polyacrylamide gels, and the data
were analyzed by using PHOSPHORIMAGER and IMAGEQUANT software (Molecular
Dynamics). Cleavage is observed at the base 3 to the CC mismatch on the
shorter strand. For comparison, the specific binding affinity of the correspond-
ing chrysi complex to this site is 3.1  105 M1.
Fig. 5. Comparisons of photocleavage of genomic DNA obtained from
various cancer cell lines. SW620 is a mismatch-repair competent cell line;
HCT15 contains a mutation in MSH6, a redundant repair protein, whereas
SKOV3 and DU145 are mismatch-repair compromised owing to mutations in
essential repair proteins. Photocleavage of genomic DNA was monitored by
using denaturing gel electrophoresis, as described in Materials and Methods.
Photocleavage by the mismatch-specific probes correlates with previous stud-
ies of mismatch-repair activity in these cell lines.
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means to distinguish among these different cell lines based on
their mismatch repair activity.
Targeting and discrimination among different genomic
DNAs, therefore, can be considered based on the increased
frequency of mispairing in genomic DNA from mismatch re-
pair deficient cells. Because the metal complexes are specific
in targeting mismatches, their levels of photocleavage should
reflect the levels of mismatches accumulated. The heteroge-
neity in fragment length both before and after photocleavage
makes absolute quantitation of the frequency of mismatches
in these cell lines difficult. Nonetheless, differential DNA
cleavage is evident among these cell lines with nanomolar
concentrations of the metal complex. It is also noteworthy
that the results described thus far reflect overall mismatch
accumulation in the genome. By probing individual genes
through photocleavage, gene-specific analyses could also be
envisioned.
Implications for Therapeutic Design. Whereas chemotherapy in
the past has focused largely on applications of cytotoxic
agents lacking selectivity, current strategies are directed at
developing means to discriminate and selectively target can-
cerous cells. Discrimination based on mismatch recognition
offers the opportunity for such selective targeting. Defects in
the mismatch repair system are commonly associated with
different cancers (2, 16). By specifically targeting the genomic
DNA of such cancerous cells with small molecules that recog-
nize and generate lesions in mismatch-containing DNA, pref-
erential damage to cancerous cells could be generated. The
design and application of bulky metallointercalators that bind
mismatches with high affinity, as described here, represent a
foundation for such strategies. Complexes have been designed
with high selectivity for mismatches and with high affinity.
Moreover, the differential targeting of genomic DNA from
cell lines based on their compromised mismatch repair sys-
tems has been demonstrated. Creating new generations of
complexes with applicability in vivo remains a challenge, but
the diversity in structure afforded by octahedral metal-
lointercalators should make such design viable.
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